Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

4Recruiting trials

Regulatory Watchboard

4 events

Dec 2024Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD

Hospices Civils de Lyon — PHASE2

TrialRECRUITING

Mar 2024Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Tenaya Therapeutics — PHASE1

TrialRECRUITING

Feb 2022Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy

University Hospital, Toulouse — NA

TrialRECRUITING

Feb 2018Mayo AVC Registry and Biobank

Mayo Clinic

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant.
Check the disease page for updates →

Clinical Trial Landscape

4 active trials

1Phase 2

1Phase 1

1N/A

1Unknown

4Total recruiting

Search clinical trials for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant →

Recent News & Research

No recent news articles indexed yet for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant.
Search PubMed for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant →

Browse all Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant news →

Specialist Network

No specialists currently listed for Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant.

View all Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰